Dexamethasone could improve myocardial infarction outcomes and provide new therapeutic options for non-interventional patients

Medical Hypotheses

Volumn 67, Issue 1, 2006, Pages 53-56

  Alisky, Joseph Martin ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; CYANOCOBALAMIN; DEXAMETHASONE; FIBRINOLYTIC AGENT; FOLIC ACID DERIVATIVE; HOMOCYSTEINE; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MEVINOLIN; MINERALOCORTICOID; PANTOPRAZOLE; PREDNISONE; PROTON PUMP INHIBITOR; SIMVASTATIN; STEROID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANGIOPLASTY; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIAC PATIENT; CELL PROLIFERATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DIABETIC PATIENT; DRUG INDUCED DISEASE; FLUID RETENTION; HEART INFARCTION; HEART MUSCLE INJURY; HOMOCYSTINURIA; HUMAN; INFECTION; OSTEOPOROSIS; PRIORITY JOURNAL; PSYCHOSIS; ULCER;

CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 33646106091     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.12.034     Document Type: Article

References (28)

1. Wallbert-Jonsson S., Ohman M., and Rantapaa-Dahlqvist S. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?. Scand J Rheumatol 33 6 (2004) 373-379
2. Roman M.J., Shanker B.-A., Davis A., Lockshin M.D., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 25 (2003) 2399-2406
3. del Rincon I., and Escalante A. Atherosclerotic cardiovascular disease in rheumatoid arthritis. Curr Rheumatol Rep 5 4 (2003) 278-286
4. Vassalli G., Gallino A., Weis M., von scheidt W., et al. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 24 13 (2003) 1180-1188
5. Fonarow G.C., Wright R.S., Spencer F.A., et al. Effect of statin use within the first 24 h of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 96 (2005) 611-616
6. Kwak B., Mulhaupt F., Myit S., and Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 6 12 (2000) 1399-1402
7. Penfold P.L., Wong J.C., Gyory J., and Billson F.A. Effects of triamcinalone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clin Exp Opthalmol 29 3 (2001) 188-192
8. Cavallero C., Di Tondo U., Mingazzini P.L., et al. Cell proliferation in the atherosclerotic plaques of cholesterol-fed rabbits. Part 3. Histological and radioautographic observations on glucocorticoids-treated rabbits. Atherosclerosis 25 2-3 (1976) 145-152
9. Bitzer M., Wiskirchen J., Schober W., et al. Moglichkeiten der prophylaxe von arteriellen restenosen mit dexamethason - eine in vitro-studie an humanen aortalen glatten muskelzellen (article in German) [Possibilities of the prophylaxis of arterial restenoses with dexamethasone - an in vitro study of human aortic smooth muscle cells]. Rofo Fortschr Geb Rontgenstr Nuklearmed 176 10 (2004) 1485-1492
10. Asai K., Funaki C., Hayashi T., Yamada K., et al. Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. possible mechanisms. Arterioscler Thromb 13 6 (1993) 892-899
11. Poon M., Gertz S.D., Fallon J.T., et al. Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits. Atherosclerosis 155 2 (2001) 371-380
12. Boyle J.J. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3 1 (2005) 63-68
13. Valen G., Kawakami T., Tahepold P., et al. Glucocorticoid pretreatment protects cardiac function and induces cardiac heat shock protein 72. Am J Physiol Heart Circ Physiol 279 2 (2000) H836-H843
14. Patti G., Pasceri V., Carminati P., et al. Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 95 (2005) 502-505
15. Versaci F., Gaspardone A., Tomai F., et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (Impress study). J Am Coll Cardiol 40 11 (2002) 1935-1942
16. Kakio T., Matsumori A., Ohashi N., et al. Hydrocortisone reduces restenosis after stenting small coronary arteries. J Interv Cardiol 17 5 (2004) 295-300
17. Pepine C.J., Hirshfeld J.W., Macdonald R.G., et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 81 6 (1990) 1753-1761
18. Lee C.W., Chae J.K., Lim H.Y., et al. Prospective randomized trial of corticosteroids for the prevention of restenosis after intracoronary stent implantation. Am Heart J 138 1 Pt 1 (1999) 60-63
19. Stone G.W., Rutherford B.D., McConahay D.R., et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn 18 4 (1989) 227-231
20. Kuchulakanti P., and Waksman R. Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis. Drugs 64 21 (2004) 2379-2388
21. Alurkar V.M., and Cherian G. Corticosteroid therapy in acute myocardial infarction. J Assoc Physicians India 26 8 (1978) 721-725
22. Peters R.W., Norman A., Parmley W.W., et al. Effect of therapy with methylprednisolone on the size of myocardial infarcts in man. Chest 73 4 (1978) 483-488
23. Barzilai D., Plavnick J., Hazani A., et al. Use of hydrocortisone in the treatment of acute myocardial infarction. Summary of a clinical trial in 446 patients. Chest 61 5 (1972) 488-491
24. Kones R.J. Glucocorticoid therapy for acute myocardial infarction. Acta Cardiol 30 5 (1975) 353-374
25. Metz C.A., Stubbs D.R., and Hearron M.S. Significance of infarct size and methylprednisolone on survival following acute myocardial infarction. J Int Med Res 14 Suppl 1 (1986) 11-14
26. Bush C.A., Renner W., and Boudoulas H. Corticosteroids in acute myocardial infarction. Angiology 31 10 (1980) 710-714
27. Guigliano G.R., Giugliano R.P., Gibson C.M., and Kuntz R.E. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol 91 (2003) 1055-1059
28. Martinez-Taboada V.M., Bartolome M.J., and Fernandez-Gonzalez M.D. Homocysteine levels in polymyalgia rhuematica and giant cell arteritis: influence of corticosteroid therapy. Rheumatology (Oxford) 42 9 (2003) 1055-1061